COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,224 Articles (22,733 medRxiv, 8,491 bioRxiv)

Most recent first Previous |  Page 2521: Articles 25201-25210  | Next

Diverse local epidemics reveal the distinct effects of population density, demographics, climate, depletion of susceptibles, and intervention in the first wave of COVID-19 in the United States
Afshordi, N., Holder, B., Bahrami, M., Lichtblau, D.
10.1101/2020.06.30.20143636 — Posted: 2020-07-02 Discussion: Onsite
Low-Impact Social Distancing Interventions to Mitigate Local Epidemics of SARS-CoV-2
Jackson, M. L.
10.1101/2020.06.30.20143735 — Posted: 2020-07-02
Positivity of SARS-CoV-2, by RT-PCR among workers of a Public Hospital in the city of Santos, SP, Brazil 2020.
CASEIRO, M. M., Mazzurana, M., Barreiro, B., Barbosa, E. C., Barbosa, A. P.
10.1101/2020.06.30.20143529 — Posted: 2020-07-02
Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain
Martinez de Salazar, P., Gomez-Barroso, D., Pampaka, D., Gil, J. M., Penalver, B., Fernandez-Escobar, C., Lipsitch, M., Larrauri, A., Goldstein, E., Hernan, M.
10.1101/2020.06.30.20143560 — Posted: 2020-07-02
Using the infection fatality rate to predict the evolution of Covid-19 in Brazil
Santos Cecconello, M., Diniz, G. L., Silva, E. B.
10.1101/2020.07.01.20144279 — Posted: 2020-07-02
Social-distancing effectiveness tracking of the COVID-19 hotspot Stockholm
Oberhammer, J.
10.1101/2020.06.30.20143487 — Posted: 2020-07-02
A genome epidemiological study of SARS-CoV-2 introduction into Japan
Sekizuka, T., Itokawa, K., Hashino, M., Kawano-Sugaya, T., Tanaka, R., Yatsu, K., Ohnishi, A., Goto, K., Tsukagoshi, H., Ehara, H., Sadamasu, K., Taira, M., Shibata, S., Nomoto, R., Hiroi, S., Toho, M., Shimada, T., Matsui, T., Sunagawa, T., Kamiya, H., Yahata, Y., Yamagishi, T., Suzuki, M., Wakita, T., Kuroda, M., COVID-19 Genomic Surveillance Network in Japan
10.1101/2020.07.01.20143958 — Posted: 2020-07-02 Discussion: Onsite
Broad phenotypic alterations and potential dysfunctions of lymphocytes in COVID-19 recovered individuals
Yang, J., Zhong, M., Zhang, E., Hong, K., Yang, Q., Zhou, D., Xia, J., Chen, Y.-Q., Sun, M., Zhao, B., Xiang, J., Liu, Y., Han, Y., Zhou, X., Huang, C., Shang, Y., Yan, H.
10.1101/2020.07.01.20144030 — Posted: 2020-07-02 Discussion: Onsite | Offsite
Identifying main and interaction effects of risk factors to predict intensive care admission in patients hospitalized with COVID-19: a retrospective cohort study in Hong Kong
Zhou, J., Tse, G., Lee, S., Liu, T., Wu, W. K., cao, z., Zeng, D., Wong, I. C., Zhang, Q., Cheung, B. M.
10.1101/2020.06.30.20143651 — Posted: 2020-07-02
Relative COVID-19 viral persistence and antibody kinetics
Huang, C.-G., Huang, C.-T., Dutta, A., Chang, P.-Y., Hsiao, M.-J., Hsieh, Y.-C., Shih, S.-R., Tsao, K.-C., Yang, C.-T.
10.1101/2020.07.01.20143917 — Posted: 2020-07-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).